Filing Details
- Accession Number:
- 0000899243-19-019150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-03 16:17:11
- Reporting Period:
- 2019-07-01
- Accepted Time:
- 2019-07-03 16:17:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742587 | Uma Sinha | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-01 | 14,000 | $17.00 | 14,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
